Covid-19: Clinical support

Controlled drugs:

Dealing with Controlled Drugs during the pandemic

Drug alert: Emerade solution for injection pre-filled syringe 300mcg

Patient safety:

COVID-19: Important patient safety update

General clinical case definition updated to include new symptoms

Immunomodulatory drugs Pregnancy Prevention Programme – temporary amendments to guidance during COVID-19 pandemic

Action required – CAS alert

Medicines supply:

Early Access to Medicines Scheme for remdesivir in the treatment of COVID-19

Serious Shortage Protocol (SSP) for fluoxetine capsules 40mg comes into effect from 20 May 2020 

DHSC update on ranitidine supply disruption 6 May 2020

Supplying methadone to housebound patients due to self-isolation or shielding

Chloroquine and hydroxychloroquine

Further reading from Gov.uk

Epidemiology, virology and clinical features

Investigation and initial clinical management of possible cases